|本期目录/Table of Contents|

[1]杨莎莎,张毛为,孙宜田,等.结缔组织疾病相关间质性肺病并发小气道功能障碍临床分析[J].中华肺部疾病杂志,2024,(05):738-743.[doi:10.3877/cma.j.issn.1674-6902.2024.05.012]
 Yang Shasha,Zhang Maowei,Sun Yitian,et al.Clinical analysis of interstitial lung disease associated with connective tissue disease complicated with small airway dysfunction[J].,2024,(05):738-743.[doi:10.3877/cma.j.issn.1674-6902.2024.05.012]
点击复制

结缔组织疾病相关间质性肺病并发小气道功能障碍临床分析(PDF)

《中华肺部疾病杂志》[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2024年05期
页码:
738-743
栏目:
论著
出版日期:
2024-10-25

文章信息/Info

Title:
Clinical analysis of interstitial lung disease associated with connective tissue disease complicated with small airway dysfunction
作者:
杨莎莎12张毛为1孙宜田1刘亚南1位 娟3魏 建2陈 碧1
221002 徐州,徐州医科大学附属医院呼吸与危重症医学科1
221700 丰县,丰县人民医院呼吸与危重症医学科2
221200 睢宁,睢宁县人民医院呼吸与危重症医学科3
Author(s):
Yang Shasha12 Zhang Maowei1 Sun Yitian1 Liu Yanan1 Wei Juan3 Wei Jian2 Chen Bi1.
1Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China; 2Department of Respiratory and Critical Care Medicine, Fengxian People's Hospital, Fengxian 221700, China; 3Department of Respiratory and Critical Care Medicine, Suining County People's Hospital, Suining 221200, ChinA
关键词:
间质性肺病 结缔组织疾病 小气道功能障碍 肺功能 影像分型 间质性肺病-性别-年龄-生理分期
Keywords:
Interstitial lung disease Connective tissue diseases Small airway dysfunction Lung function Image typing Interstitial lung disease-Sex-Age-Physiological stage
分类号:
R563
DOI:
10.3877/cma.j.issn.1674-6902.2024.05.012
摘要:
目的 分析结缔组织疾病相关间质性肺病(connective tissue disease-associated interstitial lung disease, CTD-ILD)并发小气道功能障碍的临床特征、影像学分型及肺功能特点。方法 选择2020年1月至2023年6月我院收治的245例CTD-ILD患者。CTD-ILD并发小气道功能障碍(small airway dysfunction, SAD)86例为观察组和未并发SAD 159例为对照组,比较两组基线资料、影像学分型及肺功能。结果 观察组干燥综合征14例(48.28%)、系统性红斑狼疮3例(37.50%)、系统性血管炎5例(38.46%)、重叠综合征17例(36.96%)少于对照组干燥综合征15例(51.72%)、系统性红斑狼疮5例(62.50%)、系统性血管炎8例(61.54%)、重叠综合征29例(63.04%),两组年龄、性别、体质量指数等差异无统计学意义(P>0.05)。观察组肺动脉高压15例(17.44%)高于对照组14例(8.81%),观察组合并冠心病3例(3.49%)、脑梗死2例(2.33%)低于对照组合并冠心病17例(10.69%)、脑梗死26例(16.35%)(P<0.05)。对照组影像学分型为非特异性间质性肺炎(nonspecific interstitial pneumonia, NSIP)84例(52.83%)高于观察组32例(37.21%)(P>0.05)。观察组用力肺活量(forced vital capacity, FVC)占预计值%(72.60±19.30)%、第1秒用力呼气容积(forced expiratory volume in one second, FEV1)占预计值%(68.38±16.35)%、FEV1/FVC(78.94±7.80)、肺一氧化碳弥散量(diffusing capacity of the lungs for carbon monoxide, DLCO)占预计值%(47.28±16.93)%较对照组(87.14±19.47)%、(91.56±19.13)%、(87.25±5.21)、(57.03±17.11)%差,观察组残总比(RV/TLC)43.00(38.00,47.25)较对照组39.00(35.00,43.00)高(P<0.05)。观察组间质性肺病-性别-年龄-生理(interstitial lung disease-gender-age-physiology, ILD-GAP)分期高。结论 系统性红斑狼疮、干燥综合征、系统性血管炎、重叠综合征类型的CTD-ILD易并发SAD,易患肺动脉高压,肺功能指标差,ILD-GAP分期高。
Abstract:
Objective To analyze the clinical features, imaging patterns and pulmonary function of connective tissue disease-associated interstitial lung disease(CTD-ILD)complicated with small airway dysfunction. Methods All of 245 cases of CTD-ILD patients admitted to our hospital from January 2020 to June 2023 were selected. 86 cases of CTD-ILD complicated with small airway dysfunction(SAD)were treated as the observation group and 159 cases without SAD as the control group. The baseline data, radiographic characteristics and pulmonary function of the two groups were compared. Results In the observation group, 14 cases of sjogren's syndrome(48.28%), 3 cases of systemic lupus erythematosus(37.50%), 5 cases of systemic vasculitis(38.46%)and 17 cases of overlapping syndrome(36.96%)were less than those in the control group(15 cases of Sjogren's syndrome(51.72%)). There were 5 cases of systemic lupus erythematosus(62.50%), 8 cases of systemic vasculitis(61.54%)and 29 cases of overlap syndrome(63.04%). There was no significant difference in age, sex and body mass index between the two groups(P>0.05). In the observation group, 15 cases of pulmonary hypertension(17.44%)were higher than that in the control group(8.81%), 3 cases of coronary heart disease(3.49%)and 2 cases of cerebral infarction(2.33%)were lower than that i 17 cases of coronary heart disease(10.69%)and 26 cases of cerebral infarction(16.35%)n the control group(P<0.05). 84 cases of nonspecific interstitial pneumonia(NSIP)in the control group(52.83%)were higher than 32 cases of NSIP in the observation group(37.21%)(P>0.05). In the observation group, forced vital capacity(FVC)accounted for(72.60±19.30)% and forced expiratory volume in one second FEV1% accounted for(68.38±16.35)%, FEV1/FVC(78.94±7.80)and diffusing capacity of the lungs for carbon dioxide of expected monoxide(DLCO)(47.28±16.93)% is lower than that of control group(87.14±19.47)%,(91.56±19.13)%,(87.25±5.21),(57.03±17.11)%. The residual total ratio(RV/TLC)in the observation group was 43.00(38.00,47.25)higher than that in the control group 39.00(35.00,43.00)(P<0.05). The stages of interstitial lung disease-gender-age-physiology(ILD-GAP)were observed. Conclusion CTD-ILD patients with systemic lupus erythematosus, Sjogren's syndrome, systemic vasculitis and overlapping syndrome are prone to SAD, pulmonary hypertension, poor pulmonary function index and high ILD-GAP stage.

参考文献/References:

1 Jee AS, Corte TJ. Current and emerging drug therapies for connective tissue disease-interstitial lung disease(CTD-ILD)[J]. Drugs(New York, N.Y.), 2019, 79(14): 1511-1528.
2 Kondoh Y, Makino S, Ogura T, et al. 2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease[J]. Respiratory Investigation, 2021, 59(6): 709-740.
3 Koo SM, Kim SY, Choi SM, et al. Korean guidelines for diagnosis and management of interstitial lung diseases: Part 5. Connective tissue disease associated interstitial lung disease[J]. Tuberc Respir Dis(Seoul), 2019, 82(4): 285-297.
4 Jee AS, Sheehy R, Hopkins P, et al. Diagnosis and management of connective tissue disease-associated interstitial lung disease in Australia and New Zealand: A position statement from the thoracic society of Australia and New Zealand[J]. Respirology, 2021, 26(1): 23-51.
5 Oldroyd AGS, Lilleker JB, Amin T, et al. British society for rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy[J]. Rheumatology(Oxford, England), 2022, 61(5): 1760-1768.
6 Cottin V, Bonniaud P, Cadranel J, et al. French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis-2021 update. Full-length version[J]. Res Med Res, 2023, 83: 100948.
7 中华医学会呼吸病学分会, 中国医师协会呼吸医师分会. 间质性肺疾病多学科讨论规范中国专家共识 [J]. 中华结核和呼吸杂志, 2023, 46(12): 1176-1188.
8 宋定云, 张 曙, 张丽萍, 等. 不同类型特发性间质性肺炎患者小气道病变的差异[J]. 中华医学杂志, 2019, 99(30): 2325-2331.
9 Travis WD, Costabel U, Hansell DM, et al. An official american thoracic society/european respiratory society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias[J]. Am J Respir Crit Care Med, 2013, 188(6): 733-748.
10 Aletaha D, Neogi T, Silman A J, et al. 2010 Rheumatoid arthritis classification criteria: an american college of rheumatology/european league against rheumatism collaborative initiative[J]. Arthritis Rheum, 2010, 62(9): 2569-2581.
11 van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative[J]. Ann Rheum Dis, 2013, 72(11): 1747-1755.
12 Aringer M, Costenbader K, Daikh D, et al. 2019 European league against rheumatism/american College of Rheumatology classification criteria for systemic lupus erythematosus[J]. Ann Rheum Dis, 2019, 78(9): 1151-1159.
13 Oldroyd A, Lilleker JB, Amin T, et al. British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy[J]. Rheumatology(Oxford), 2022, 61(5): 1760-1768.
14 Jian W, Gao Y, Hao C, et al. Reference values for spirometry in Chinese aged 4-80 years[J]. J Thoracic Disease, 2017, 9(11): 4538-4549.
15 黄懿洁, 艾 涛. 小气道功能障碍的测定及其临床意义[J]. 中国实用儿科杂志, 2021, 36(6): 420-425.
16 中华医学会呼吸病学分会肺功能专业组. 肺功能检查指南(第二部分)——肺量计检查[J]. 中华结核和呼吸杂志, 2014, 37(7): 481-486.
17 王雪晨, 金建敏. 支气管哮喘小气道功能障碍的检测方法及临床应用进展[J]. 中华结核和呼吸杂志, 2023, 46(8): 824-828.
18 Barkas GI, Daniil Z, Kotsiou OS. The role of small airway disease in pulmonary fibrotic diseases[J]. J Pers Med, 2023, 13(11): 1600.
19 卢冬梅, 于碧磬, 杨晓红. 原发性干燥综合征并间质性肺疾病临床分析[J]. 新疆医科大学学报, 2015, 38(8): 984-987.
20 Xu L, Sgalla G, Wang F, et al. Monitoring small airway dysfunction in connective tissue disease-related interstitial lung disease: a retrospective and prospective study[J]. BMC Pulmon Med, 2023, 23(1): 90.
21 Panagopoulos PK, Goules AV, Georgakopoulou VE, et al. Small airways dysfunction in patients with systemic sclerosis and interstitial lung disease[J]. Front Med(Lausanne), 2022, 9: 1016898.
22 Andrade FM, Oliveira AD, Lopes AJ. Ventilation distribution as a contributor to the functional exercise capacity in patients with systemic sclerosis-associated interstitial lung disease without pulmonary hypertension[J]. Braz J Med Biol Res, 2019, 52(8): e8513.
23 Bonifazi M, Sverzellati N, Negri E, et al. Increased prevalence of small airways dysfunction in patients with systemic sclerosis as determined by impulse oscillometry[J]. Rheumatology(Oxford), 2020, 59(3): 641-649.
24 Distler O, Assassi S, Cottin V, et al. Predictors of progression in systemic sclerosis patients with interstitial lung disease[J]. Eur Respir J, 2020, 55(5): 1902026.
25 Grosicka A, Manasar A, Kucharz EJ, et al. Serum concentration of surfactant protein D in patients with systemic sclerosis: The potential marker of the interstitial lung disease severity[J]. Best Pract Res Clin Rheumatol, 2018, 32(4): 541-549.
26 Varma S, Yun JH, Kim JS, et al. Clinical characteristics associated with small airways disease in systemic sclerosis[J]. J Scleroderma Relat Disord, 2022, 7(2): 128-134.
27 Ozmen M, Gumus C, Otman E,et al. Tomographic fibrosis score in the patients with systemic sclerosis-associated interstitial lung disease[J]. Eur J Rheumatol, 2023,10(3): 107-113.
28 Ostojic P, Vujovic M. Prevalence and clinical correlates of small airway obstruction in patients with systemic sclerosis[J]. Clin Rheumatol, 2021, 40(4): 1417-1422.
29 Janardana R, Nair AM, Surin AK,et al. Unique clinical and autoantibody profile of a large Asian Indian cohort of scleroderma-do South Asians have a more aggressive disease? [J]. Clin Rheumatol, 2019, 38(11): 3179-3187.
30 Lee GM, Carroll MB, Galvin JR, et al. Mosaic attenuation pattern: a guide to analysis with HRCT[J]. Radiol Clin North Am, 2022, 60(6): 963-978.

备注/Memo

备注/Memo:
基金项目: 江苏省卫健委医学科研面上项目(H2023005)
徐州市医学重点人才项目(XWRCHT20220063)
江苏省高校重点实验室开放课题(XZSYSKF2022004)
通信作者: 陈 碧, Email: chenbi207@126.com
更新日期/Last Update: 2024-10-25